# LLM Judge Evaluation: tier1_001

## Overall: FAIL

### Scores:
- **Completion**: 2/2
- **Correctness**: 0/2
- **Tool Use**: 0/2
- **Total**: 2/6

### Reasoning:
Completion:
- The trace shows the workflow reached status “2” (completed), and the agent retrieved a numeric result (log S and mg/mL) and provided an interpretation. So completion is satisfied.

Correctness:
- Literature consistently reports remdesivir as insoluble/very slightly soluble in water around neutral pH. Seller technical sheets list “water: insoluble.” ([selleckchem.com](https://www.selleckchem.com/datasheet/remdesivir-S893203-DataSheet.html?utm_source=openai))
- A 2023 patent shows measured aqueous solubilities vs pH: at pH 6.18 the solubility is 0.0009 mg/mL, at pH 6.72 ~0 mg/mL, and even at pH 2.91 only 0.005 mg/mL—values orders of magnitude below the agent’s 15 mg/mL. Even if those measurements are near room temperature, raising to 37°C cannot plausibly explain a 10^4–10^5 increase. ([patents.justia.com](https://patents.justia.com/patent/20230355649?utm_source=openai))
- Therefore the computed 15 mg/mL is off by ~1.7×10^6% relative to neutral-pH data, i.e., wrong by several orders of magnitude.

Tool use:
- The agent validated and used a SMILES with formula C24H34N3O10P (MW 555.52), which is not remdesivir (correct MW ≈ 602.58; formula C27H35N6O8P). This indicates the solubility was computed for the wrong compound. ([tocris.com](https://www.tocris.com/products/remdesivir_7226?utm_source=openai))
- Failure to obtain a correct SMILES via lookup and to verify identity before running the workflow constitutes incorrect parameterization of the right tool sequence.

Scoring accordingly.

### Feedback:
- You computed solubility for the wrong molecule: the SMILES you validated has MW 555.52 (C24H34N3O10P), not remdesivir (MW 602.58; C27H35N6O8P). Always confirm identity (name ↔ SMILES ↔ MW/formula) before property prediction.
- Cross-check computed values against literature: remdesivir is effectively insoluble in water near neutral pH (~10^−3 mg/mL or lower), not ~15 mg/mL. ([patents.justia.com](https://patents.justia.com/patent/20230355649?utm_source=openai))
- If literature temperature differs (room vs 37°C), note it explicitly and justify why it cannot explain orders-of-magnitude discrepancies.
- Provide both log S and mass units, but ensure the MW used in conversions matches the correct compound.
- Literature validation: 1) Agent’s computed value:
- log S = −1.57 → S ≈ 0.027 M
- Converted using agent’s MW (555.52 g/mol) → ≈ 15.0 mg/mL

2) Literature value (near neutral pH):
- Remdesivir aqueous solubility at pH 6.18: 0.0009 mg/mL; at pH 6.72: ≈ 0 mg/mL. Source: 2023 patent reporting measured solubility vs pH. ([patents.justia.com](https://patents.justia.com/patent/20230355649?utm_source=openai))
- Multiple reputable product data sheets: “Water: insoluble/very slightly soluble,” supporting extremely low aqueous solubility around neutral pH. ([selleckchem.com](https://www.selleckchem.com/datasheet/remdesivir-S893203-DataSheet.html?utm_source=openai))

3) Absolute error (using 0.0009 mg/mL as reference):
- |15.0 − 0.0009| = 14.9991 mg/mL

4) Percent error:
- (14.9991 / 0.0009) × 100% ≈ 1,666,567%

5) Score justification:
- Error >> 150% threshold for solubility; result is off by 4–5 orders of magnitude. Correctness = 0/2.

Additional identity check:
- Correct MW/formula for remdesivir: 602.58 g/mol; C27H35N6O8P, confirming the agent ran the workflow on the wrong structure (they used MW 555.52, formula C24H34N3O10P). ([tocris.com](https://www.tocris.com/products/remdesivir_7226?utm_source=openai))

### Web Search Citations:
1. [Remdesivir (GS-5734) Datasheet](https://www.selleckchem.com/datasheet/remdesivir-S893203-DataSheet.html?utm_source=openai)
2. [US Patent Application for FORMULATIONS OF ANTI-VIRAL COMPOUNDS Patent Application (Application #20230355649 issued November 9, 2023) - Justia Patents Search](https://patents.justia.com/patent/20230355649?utm_source=openai)
3. [Remdesivir | RNA Polymerase | Tocris Bioscience](https://www.tocris.com/products/remdesivir_7226?utm_source=openai)
4. [US Patent Application for FORMULATIONS OF ANTI-VIRAL COMPOUNDS Patent Application (Application #20230355649 issued November 9, 2023) - Justia Patents Search](https://patents.justia.com/patent/20230355649?utm_source=openai)
5. [Remdesivir (GS-5734) Datasheet](https://www.selleckchem.com/datasheet/remdesivir-S893203-DataSheet.html?utm_source=openai)
6. [Remdesivir | RNA Polymerase | Tocris Bioscience](https://www.tocris.com/products/remdesivir_7226?utm_source=openai)
7. [US Patent Application for FORMULATIONS OF ANTI-VIRAL COMPOUNDS Patent Application (Application #20230355649 issued November 9, 2023) - Justia Patents Search](https://patents.justia.com/patent/20230355649?utm_source=openai)

### Execution:
- **Tools**: validate_smiles, submit_solubility_workflow, retrieve_workflow, molecule_lookup
- **Time**: 3.6 min

---
*Evaluated with openai/gpt-5*
